miconazole has been researched along with vancomycin in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (17.65) | 18.7374 |
| 1990's | 4 (23.53) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Bhargava, A; Singh, RK; Srivastava, R | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bremner, JB; Casadei, G; Chen, C; Doll, NK; Kelso, MJ; Lewis, K | 1 |
| Mishra, NN; Prabhakar, YS; Saquib, M; Sharma, S; Shaw, AK; Shukla, PK; Srivastava, R; Verma, S | 1 |
| Giang, NTK; Huong, DT; Quyen, TH; Thanh, ND; Toan, VN | 1 |
| Dang, LH; Dung, TT; Hai, DS; Kim Van, HT; Ky Duyen, NT; Mai, NT; Ngoc Bich, VT; Thanh Van, TT; Thanh, ND; Thu Hien, PT; Toan, DN; Toan, VN | 1 |
| Dinh Thanh, N; Minh Tri, N; Ngoc Toan, V; Thi Thu Huong, N | 1 |
| Alexander-Williams, J; Arabi, Y; Brown, JD; Burdon, DW; George, RH; Keighley, MR; Shinagawa, N; Youngs, DJ | 1 |
| Bercy, P; De Beule, F; Ferrant, A | 1 |
| Kawasaki, K; Mochizuki, K; Shirao, Y; Tanabe, J; Torisaki, M; Wakabayashi, K; Yamashita, Y | 1 |
| Crane, LR; Duman, K; Hatfield, SM; Karanes, C; Kiel, RJ | 1 |
| Moellering, RC; Murray, BE | 1 |
| Maezawa, H; Nakazawa, Y; Saito, A; Sakai, O; Sakamoto, M; Shiba, K; Shindou, N; Yoshida, M; Yoshikawa, K | 1 |
| Aristimuño, B; Hemady, RK; Nirankari, VS; Rodrigues, MM | 1 |
| Ebihara, M; Hosoya, J; Nakagawa, Y; Ojima, F; Shoji, T; Toyoguchi, T | 1 |
1 review(s) available for miconazole and vancomycin
| Article | Year |
|---|---|
Antimicrobial agents in pulmonary infections.
Topics: Aminoglycosides; Amphotericin B; Anti-Infective Agents; Cephalosporins; Cephamycins; Chloramphenicol; Clindamycin; Erythromycin; Flucytosine; Humans; Miconazole; Penicillins; Respiratory Tract Infections; Tetracycline; Vancomycin | 1980 |
16 other study(ies) available for miconazole and vancomycin
| Article | Year |
|---|---|
Synthesis and antimicrobial activity of some novel nucleoside analogues of adenosine and 1,3-dideazaadenosine.
Topics: Adenosine; Anti-Infective Agents; Bacteria; Fungi; Microbial Sensitivity Tests; Molecular Structure; Tubercidin | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Diarylacylhydrazones: Clostridium-selective antibacterials with activity against stationary-phase cells.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cell Cycle; Cell Line; Clostridioides difficile; Fidaxomicin; Humans; Hydrazones; Microbial Sensitivity Tests | 2014 |
Synthesis of 2,3,6-trideoxy sugar triazole hybrids as potential new broad spectrum antimicrobial agents.
Topics: Anti-Infective Agents; Bacteria; Carbohydrates; Catalytic Domain; Cell Line; Chemistry Techniques, Synthetic; Click Chemistry; Drug Design; Fungi; Microbial Sensitivity Tests; Models, Molecular; Penicillin-Binding Proteins; Triazoles | 2014 |
Synthesis and evaluation of in vivo antioxidant, in vitro antibacterial, MRSA and antifungal activity of novel substituted isatin N-(2,3,4,6-tetra-O-acetyl-β-d-glucopyranosyl)thiosemicarbazones.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antioxidants; Cell Line, Tumor; Chemistry Techniques, Synthetic; Drug Evaluation, Preclinical; Isatin; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Rats; Rats, Wistar; Structure-Activity Relationship; Thiosemicarbazones | 2016 |
Efficient click chemistry towards novel 1H-1,2,3-triazole-tethered 4H-chromene-d-glucose conjugates: Design, synthesis and evaluation of in vitro antibacterial, MRSA and antifungal activities.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Benzopyrans; Click Chemistry; Drug Design; Fungi; Glucose; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; RAW 264.7 Cells; Triazoles | 2019 |
Synthesis and biological screening of thiosemicarbazones of substituted 3-acetylcoumarins having d-glucose moiety.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacteria; Bacterial Infections; Coumarins; Fungi; Glucose; Humans; Microbial Sensitivity Tests; Mycoses; Structure-Activity Relationship; Thiosemicarbazones | 2020 |
Antibiotic susceptibility of Clostridium difficile.
Topics: Anti-Bacterial Agents; Clostridium; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Humans; Miconazole; Microbial Sensitivity Tests; Vancomycin | 1979 |
The effectiveness of a preventive regimen on the periodontal health of patients undergoing chemotherapy for leukemia and lymphoma.
Topics: Acyclovir; Amphotericin B; Ceftazidime; Chlorhexidine; Dental Plaque Index; Fluconazole; Humans; Immunosuppression Therapy; Ketoconazole; Leukemia; Lymphoma; Miconazole; Norfloxacin; Periodontal Diseases; Periodontal Index; Tooth Loss; Vancomycin | 1991 |
Electroretinographical changes due to antimicrobials.
Topics: 4-Quinolones; Adult; Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Electroretinography; Eye Infections, Bacterial; Eye Infections, Fungal; Humans; Lactams; Male; Miconazole; Rabbits; Retina; Vancomycin; Vitreous Body | 1990 |
Miconazole-induced alteration in tobramycin pharmacokinetics.
Topics: Adult; Body Weight; Bone Marrow Transplantation; Cholesterol; Drug Interactions; Female; Humans; Kinetics; Male; Miconazole; Middle Aged; Mycoses; Neutropenia; Time Factors; Tobramycin; Triglycerides; Vancomycin | 1986 |
[Treatment of severe pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA) and Candida krusei with granulocyte colony-stimulating factor (G-CSF): a case report].
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Fluconazole; Granulocyte Colony-Stimulating Factor; Humans; Lung Diseases, Fungal; Male; Methicillin Resistance; Miconazole; Pneumonia; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin | 1993 |
Spontaneous ulcerative keratitis in immunocompromised patients.
Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Adult; Amikacin; Amphotericin B; Candida albicans; Cefazolin; Ciprofloxacin; Corneal Ulcer; Female; Gentamicins; HIV Seropositivity; Humans; Miconazole; Pseudomonas aeruginosa; Staphylococcus aureus; Substance Abuse, Intravenous; Vancomycin; Visual Acuity | 1993 |
Histamine release induced by antimicrobial agents and effects of antimicrobial agents on vancomycin-induced histamine release from rat peritoneal mast cells.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Cilastatin; Dose-Response Relationship, Drug; Fluconazole; Fosfomycin; Histamine Release; Male; Mast Cells; Miconazole; Peritoneal Cavity; Rats; Rats, Wistar; Vancomycin | 2000 |